Form 4: Rivian CEO Robert Scaringe Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Rivian CEO Robert Scaringe exercised stock options and sold a portion of his shares under a pre-arranged 10b5-1 trading plan.

Summary

  • Rivian CEO Robert Scaringe exercised stock options to acquire 71,429 shares of Class A Common Stock at a price of $2.6282 per share on December 12, 2024.
  • On the same day, Scaringe sold 71,429 shares of Class A Common Stock at a weighted average price of $13.6527 per share.
  • The sale was executed automatically under a Rule 10b5-1 trading plan adopted on March 8, 2024.
  • Following these transactions, Scaringe directly owns 863,361 shares of Class A Common Stock and 7,892,405 stock options.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction by the CEO under a pre-arranged plan. It is neither particularly positive nor negative, and is a normal part of executive compensation.

Risks

  • The sale of shares by the CEO could be perceived negatively by some investors, potentially impacting the stock price.
  • The reliance on a 10b5-1 trading plan indicates a pre-determined strategy for selling shares, which may not always align with market sentiment.

Industry Context

This transaction is a routine filing for insider trading activity and is common for executives who have stock options as part of their compensation. It does not indicate any specific change in the company's performance or outlook.

Comparison to Industry Standards

  • Executive stock option exercises and sales are common across the industry, particularly in companies with equity-based compensation plans.
  • The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading, similar to what is seen at companies like Tesla and Lucid.
  • The price range of the sale is within the typical trading range for Rivian stock at the time of the transaction.

Stakeholder Impact

  • The sale of shares by the CEO could cause some short-term volatility in the stock price.
  • The transaction does not directly impact employees, customers, or suppliers.

Key Dates

DateDescription
2023-02-14Stock options fully vested.
2024-03-0810b5-1 trading plan adopted.
2024-05-07Issuer's Quarterly Report on Form 10-Q for the three months ended March 31, 2024, filed with the SEC.
2024-12-12Stock options exercised and shares sold.
2024-12-16Date of filing of the SEC Form 4.

Keywords

Rivian, Robert Scaringe, stock options, 10b5-1 trading plan, insider trading, SEC Form 4, share sale, Class A Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.